A groundbreaking handbook for activating your body''s naturally occurring weight-loss hormones without relying on medication, from the former director at Novo Nordisk, the pharmaceutical company behind Wegovy and Ozempic

In 2022, the world changed drastically when GLP-1 medications became popular in the market. But with prices soaring and production restricted, the benefits of these drugs are not accessible to all. The good news is the major component in these drugs mimics the effect of one of the body''s very own natural weight-loss hormones—so why not let your body do the work? 

For more than twenty years, Dr. Anette Sams has worked as a pharmaceutical researcher&mdash;including six years at Novo Nordisk, where she specialized in and led research on blood sugar, diabetes, and inflammation&mdash;and she''s now sharing her expertise worldwide. In <Let Your Body Do the Work<, Sams explains how the naturally occurring GLP-1 hormone works in the body and shares practical, everyday tips on how to activate it through nutrition and lifestyle tweaks.&nbsp;

This powerful hormone can not only help to achieve and maintain a healthy weight, but also regulate blood sugar and appetite, improve insulin sensitivity, reduce inflammation, support satiety, and support natural prevention of common diseases. An instant bestseller in Denmark, <Let Your Body Do the Work <is your resource for accessing the benefits of healthy, active weight-loss hormones without the hefty price tag.

"It should never be easier to get expensive injections than to understand our own hormones. The world needs both medication and education." &mdash;Anette Sams

Autorentext

Anette Sams, Ph.D., is a bestselling author and the former Director of Diabetes Complications Biology at Novo Nordisk. She is currently Affiliate Associate Professor in Translational and Clinical Pharmacology at Copenhagen University, and the author of The Truth About Sugar and Leaving Diabetes 2 Behind. Her latest title, Let Your Body Do the Work, was an instant bestseller in Denmark.

Klappentext

BALANCE HORMONES • REGULATE BLOOD SUGAR • OPTIMIZE INSULIN SENSITIVITY

A groundbreaking handbook for activating your body's naturally occurring weight-loss hormones without relying on medication, from the former director at Novo Nordisk, the pharmaceutical company behind Wegovy and Ozempic

**“The most important GLP-1 conversation no one is having.”—David Perlmutter, MD, #1 New York Times bestselling author of Grain Brain and Brain Defenders

In 2022, the world changed drastically when GLP-1 medications became popular in the market. But with prices soaring and production restricted, the benefits of these drugs are not accessible to all. The good news is the major component in these drugs mimics the effect of one of the body's very own natural weight-loss hormones—so why not let your body do the work?

For more than twenty years, Dr. Anette Sams has worked as a pharmaceutical researcher—including six years at Novo Nordisk, where she specialized in and led research on blood sugar, diabetes, and inflammation—and she's now sharing her expertise worldwide. In Let Your Body Do the Work, Sams explains how the naturally occurring GLP-1 hormone works in the body and shares practical, everyday tips on how to activate it through nutrition and lifestyle tweaks.

This powerful hormone can not only help to achieve and maintain a healthy weight, but also regulate blood sugar and appetite, improve insulin sensitivity, reduce inflammation, support satiety, and support natural prevention of common diseases. An instant bestseller in Denmark, Let Your Body Do the Work is your resource for accessing the benefits of healthy, active weight-loss hormones without the hefty price tag.

“It should never be easier to get expensive injections than to understand our own hormones. The world needs both medication and education.”—Anette Sams

Zusammenfassung
**A groundbreaking handbook for activating your body's naturally occurring weight-loss hormones without relying on medication, from the former director at Novo Nordisk, the pharmaceutical company behind Wegovy and Ozempic

“The most important GLP-1 conversation no one is having.”—David Perlmutter, MD, #1 New York Times bestselling author of Grain Brain and Brain Defenders

In 2022, the world changed drastically when GLP-1 medications became popular in the market. But with prices soaring and production restricted, the benefits of these drugs are not accessible to all. The good news is the major component in these drugs mimics the effect of one of the body's very own natural weight-loss hormones—so why not let your body do the work?

For more than twenty years, Dr. Anette Sams has worked as a pharmaceutical researcher—including six years at Novo Nordisk, where she specialized in and led research on blood sugar, diabetes, and inflammation—and she's now sharing her expertise worldwide. In Let Your Body Do the Work, Sams explains how the naturally occurring GLP-1 hormone works in the body and shares practical, everyday tips on how to activate it through nutrition and lifestyle tweaks.

This powerful hormone can not only help to achieve and maintain a healthy weight, but also regulate blood sugar and appetite, improve insulin sensitivity, reduce inflammation, support satiety, and support natural prevention of common diseases. An instant bestseller in Denmark, Let Your Body Do the Work is your resource for accessing the benefits of healthy, active weight-loss hormones without the hefty price tag.

"It should never be easier to get expensive injections than to understand our own hormones. The world needs both medication and education." —Anette Sams

Leseprobe
Chapter 1

Meet Your Capable Body

My country of Denmark as I knew it changed in December 2022. Only a few years earlier, the United States had debuted the medication that would take the world by storm, and now packs of the world’s first plausible weight-loss medicine were flying off the shelves at pharmacies from Ringkøbing to Rønne. Wegovy, Novo Nordisk’s brilliant replica of one of the body’s natural weight-loss hormones, and the medication I’ll refer to most here as it’s the one I worked directly with, appeared like a rainbow on a rainy day. And for the way the world took to it, you’d believe that a pot of gold awaited those who could find the end of the rainbow.

In the story of Novo Nordisk and Wegovy, the rainbow did in fact lead to gold. But for Wegovy users, the prize is a different story. Rather than a pot of cold cash awaiting them at the end of the rainbow, it’s a dream finally realized. For millions of people around the world, their deepest wish appears to have been answered. With a click in the abdomen using a small pen, they are able to tame their constant hunger, which normally holds them captive, much like an unassailable dictator. At the same time, they’re able to fulfill their desire to rid themselves of extra pounds around the waist, which despite restraint, constant deprivation, long plodding runs, and trips to the gym never quite seem to disappear for good.

The impact of Wegovy usage is tangible. Supermarkets report declining food sales and restaurants are serving smaller portions, while airlines spot an opportunity to save on fuel and improve their carbon footprint. People around the world face a slimmer—and perhaps healthier—future.

But with great discoveries come great dilemmas. This is also the case when looking at the success of Wegovy. Who needs the drug, and who is entitled to it? Who pays for it? There are those who steadf…